Pharmadrug Statistics

Total Valuation

Pharmadrug has a market cap or net worth of CAD 1.62 million. The enterprise value is 3.06 million.

Market Cap	1.62M
Enterprise Value	3.06M

Important Dates

The next estimated earnings date is Thursday, May 1, 2025.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Pharmadrug has 107.73 million shares outstanding. The number of shares has increased by 89.92% in one year.

Current Share Class	n/a
Shares Outstanding	107.73M
Shares Change (YoY)	+89.92%
Shares Change (QoQ)	+3.74%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	n/a
Float	107.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.23
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.10

Current Ratio	0.10
Quick Ratio	0.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.76

Financial Efficiency

Return on equity (ROE) is -381.64% and return on invested capital (ROIC) is -15.82%.

Return on Equity (ROE)	-381.64%
Return on Assets (ROA)	-12.38%
Return on Capital (ROIC)	-15.82%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.50% in the last 52 weeks. The beta is 2.73, so Pharmadrug's price volatility has been higher than the market average.

Beta (5Y)	2.73
52-Week Price Change	-62.50%
50-Day Moving Average	0.02
200-Day Moving Average	0.03
Relative Strength Index (RSI)	46.67
Average Volume (20 Days)	215,662

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.26M
Pretax Income	-14.24M
Net Income	-13.17M
EBITDA	-1.20M
EBIT	-1.26M
Earnings Per Share (EPS)	-0.14

Full Income Statement

Balance Sheet

The company has 128,121 in cash and 1.40 million in debt, giving a net cash position of -1.27 million or -0.01 per share.

Cash & Cash Equivalents	128,121
Total Debt	1.40M
Net Cash	-1.27M
Net Cash Per Share	-0.01
Equity (Book Value)	-1.31M
Book Value Per Share	-0.01
Working Capital	-1.87M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.05M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pharmadrug does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-89.92%
Shareholder Yield	-89.92%
Earnings Yield	-911.00%
FCF Yield	n/a

Stock Splits

The last stock split was on October 24, 2023. It was a reverse split with a ratio of 0.1428571.

Last Split Date	Oct 24, 2023
Split Type	Reverse
Split Ratio	0.1428571

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a